Source link : https://www.newshealth.biz/health-news/pivotal-trials-will-address-diversity-with-new-fda-initiative/
NEW YORK — Underrepresentation by gender and race in major clinical trials has been a cause for complaint for decades, but the US Food and Drug Administration (FDA) has drafted a regulatory solution to this issue expected to be implemented sometime in 2025. This initiative, known as the FDA’s Diversity Action Plan (DAP), will require […]
Author : News Health
Publish date : 2024-09-18 09:36:18
Copyright for syndicated content belongs to the linked Source.
Categories